-
Signature
-
/s/ John Burke, Attorney-in-Fact
-
Issuer symbol
-
NOVT
-
Transactions as of
-
02 Dec 2024
-
Net transactions value
-
-$314,515
-
Form type
-
4
-
Filing time
-
04 Dec 2024, 16:44:18 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
NOVT |
Common Stock |
Options Exercise |
$28,839 |
+2,041 |
+1.7% |
$14.13 |
122,460 |
02 Dec 2024 |
Direct |
F1 |
| transaction |
NOVT |
Common Stock |
Sale |
$28,530 |
-172 |
-0.14% |
$165.87 |
122,288 |
02 Dec 2024 |
Direct |
F1, F2 |
| transaction |
NOVT |
Common Stock |
Sale |
$64,400 |
-386 |
-0.32% |
$166.84 |
121,902 |
02 Dec 2024 |
Direct |
F1, F3 |
| transaction |
NOVT |
Common Stock |
Sale |
$96,739 |
-576 |
-0.47% |
$167.95 |
121,326 |
02 Dec 2024 |
Direct |
F1, F4 |
| transaction |
NOVT |
Common Stock |
Sale |
$81,130 |
-480 |
-0.4% |
$169.02 |
120,846 |
02 Dec 2024 |
Direct |
F1, F5 |
| transaction |
NOVT |
Common Stock |
Sale |
$72,556 |
-427 |
-0.35% |
$169.92 |
120,419 |
02 Dec 2024 |
Direct |
F1, F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
NOVT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,041 |
-12% |
$0.000000 |
14,420 |
02 Dec 2024 |
Common Stock |
2,041 |
$14.13 |
Direct |
F1, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: